FEATURED CONTRIBUTED CONTENT
Medical Storytelling: Combining High Science and High Emotion for High Impact
During this presentation, the speakers will share their insights on transforming medical education content from a package insert rehash into a compelling, compliant medical story. They will highlight how you can take healthcare provider audiences from being passive listeners to active participants by Capturing and keeping their attention, reception, and recall Provocatively challenging healthcare providers […]
Building a Secure, Automated Quality System to Accelerate Time to Market
Today life science companies face a perfect storm of factors driving their costs up and sales down. With 40% of R&D costs linked to paper-based processes, legacy, manual processes pose a particular threat – costing life science companies billions of dollars a year and delaying product launch and commercialization*. Boston Scientific is tackling these challenges […]
Clinical Trial Simulation (CTS) in Early Market Access Planning
In this white paper, you will learn how clinical trial simulation (CTS) can support early market access planning by predicting a range of feasible trial results of a new treatment that can be fed into an economic model, making it possible to anticipate challenges to the economic value story. By understanding these challenges at the […]
Trump Administration Issues Drug Price Transparency Proposed Rule
On October 15, the Trump Administration published a proposed rule that, if finalized, would require prescription drug makers to include drug price information in broadcast advertising. This controversial proposal would implement an idea first broached in the Administration’s drug pricing Blueprint. Learn more about the proposed rule in this white paper using the link below. […]
How Technology is Reshaping the Rare Disease Landscape
Technology is transforming clinical drug development. In the rare disease space, clinical drug development is moving away from traditional approaches that rely on patients to travel long distances to clinical sites and toward a more patient-focused paradigm. This new paradigm is especially suited to studies in patients with rare diseases; these studies target small populations of geographically dispersed patients […]
Infographic: How the 340B Discount Applies in the Hospital Setting
The 340B patient definition requires that the hospital has established a relationship with the individual such that the hospital maintains records of the individual’s health care; and the individual receives health care services from a health care professional who is either employed by the hospital or provides health care under contractual or other arrangements (e.g., referral […]
Impact of Co-pay Accumulators on Access to Specialty Therapies
Specialty medications, which have emerged as important new treatment options for complex diseases like oncology, rheumatology and neurology, now represent approximately 50% of the overall pharmaceutical market spend, according to the report, Medicine Use and Spending in the U.S. from the IQVIA Institute. While specialty therapies can be life-changing, they can also be expensive for […]
Machine Learning – Biopharma Applications and Overview of Key Steps for Successful Implementation
Evidera recently wrote an article on utilizing Machine Learning and Big Data to achieve better results. This article reviews applications that increase efficiency and allow more convincing value demonstration, broadly following a product’s lifecycle from drug discovery to drug repositioning. Key areas for Machine Learning include Drug discovery Clinical trials Wearables Pharmacovigilance Precision medicine Adherence […]
PharmaVOICE 100 Celebration 2018 – Montage
Enjoy this visual recap of the 2018 PharmaVOICE 100 Celebration. Dozens of photos, video clips, and interviews showcase the amazing talent in our industry. This year’s core topic was Transformation.
Case study: Clearing the Path to Pull-Through
Aptus Health has provided a case study on a successful Market Access Pull-Through Program. Here is a summary of the document. To capitalize on its brands’ favorable formulary positioning, we helped our client develop a Market Access Pull-Through Program (MAPP) powered by Aptus Health’s Tomorrow Networks division. The geo-targeted mobile ad campaigns were designed to […]
Key Considerations for Parkinson’s Disease Trials
Parkinson’s Disease (PD), a common neurodegenerative disorder of the central nervous system, is the subject of much R&D in the Life Sciences industry, given that there are currently no disease-modifying agents on the market. Yet, the therapeutic area poses significant challenges for clinical development— ranging from biomarker development to study design and patient recruitment and retention. There are, however, many advances […]
Three reasons why patient engagement is your secret weapon to study success
Sponsors and CROs want to be patient-centric, but it’s hard to know what exactly to do to improve the patient experience, or what the measurable benefits of keeping patients more engaged really are. In this whitepaper, you’ll learn what patient engagement actually means and the benefits of doing it right. You’ll also learn: The benefits […]
How Technology is Reshaping the Rare Disease Landscape
PRA has recently released a white paper about technology’s effects on rare disease research. Approximately 7,000 rare diseases affect an estimated 350 million people worldwide, and with diagnostic advances, new diseases are discovered every day. Although the number of clinical trials in rare diseases has increased by 56% in the last 3 years, only 5% of rare diseases […]
Providing effective support for people living with cancer: Insights from health psychology
Dr. Laura Moore discusses the concept of “chronic cancer,” and the changing treatment landscape. She talks about the challenges in supporting people as they adjust to a cancer diagnosis and engage in self-management of their illness, including treatment adherence. She explains how ongoing education and personalized support can help individuals across their treatment experience. The […]
Would CMS’s Drug Pricing Transparency Requirement Really Lower Prices?
On October 15, the Trump Administration’s Center for Medicare and Medicaid Services, CMS, published a proposed rule that, if finalized, would require prescription drug makers to include prescription drug price information in broadcast advertising. The Administration stated that it believes including the prices in ads will help consumers make better choices and, ultimately, save money […]
Women + Health – an Industry Movement
With a U.S. healthcare market estimated at $2.8 trillion and purchasing either made or largely influenced by women, the “power of the purse” has never been stronger. This special eBook is brought to you through the support of Cardinal Health. Maintaining and fostering a diverse, inclusive work environment that drives innovation, while reflecting the marketplace and communities where it operates, is […]
